Results 71 to 80 of about 7,181,436 (281)

Rationale and design of the balANZ trial: A randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal function

open access: yesBMC Nephrology, 2010
Background The main hypothesis of this study is that neutral pH, low glucose degradation product (GDP) peritoneal dialysis (PD) fluid better preserves residual renal function in PD patients over time compared with conventional dialysate.
Clarke Margaret   +4 more
doaj   +1 more source

The Effect of Hydroxychloroquine on Residual Proteinuria in Patients With Immunoglobulin A Nephropathy: A Retrospective Study Based on Propensity Score Matching

open access: yesFrontiers in Medicine, 2022
BackgroundThere is insufficient evidence to support the use of hydroxychloroquine (HCQ) in Immunoglobulin A nephropathy (IgAN) patients with high residual proteinuria in spite of 6-month supportive treatment combined with corticosteroids (P) and/or ...
Mijia Liu   +4 more
doaj   +1 more source

The Impact of Tenapanor on Body Composition and Blood Pressure in Peritoneal Dialysis Patients: A Pilot Study

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Instruction Tenapanor potentially affects fluid volume and blood pressure. This study explored its effects on these parameters in patients undergoing peritoneal dialysis (PD). Methods We conducted a single‐arm, prospective observational study that enrolled 10 patients on PD with hyperphosphatemia who were newly initiated on tenapanor.
Shun Yoshida   +11 more
wiley   +1 more source

Microwave ablation versus combined microwave ablation and transarterial chemoembolization for T1a renal cell carcinoma: a Single-Center retrospective study

open access: yesBMC Urology
Purpose This study aimed to evaluate and compare the clinical efficacy and renal function outcomes of microwave ablation (MWA) alone versus MWA combined with transarterial chemoembolization (MWA + TACE) in patients with T1a renal cell carcinoma (RCC ...
Çağrı Erdim   +4 more
doaj   +1 more source

Anemia Is a Predictor of Withdrawal from Peritoneal Dialysis in Stable Peritoneal Dialysis Patients

open access: yesKidney and Dialysis
Introduction: The association between anemia and peritoneal dialysis (PD) withdrawal in patients with stable PD remains poorly established. Herein, we investigated the relationship between anemia and PD withdrawal in patients with stable PD.
Kenta Torigoe   +9 more
doaj   +1 more source

Effects of Roxadustat on the Anemia and Iron Metabolism of Patients Undergoing Peritoneal Dialysis

open access: yesFrontiers in Medicine, 2021
Background: We investigated the effects of roxadustat on the anemia, iron metabolism, peritoneal membrane function, and residual renal function; and determined the factors associated with the administration of roxadustat in patients who were undergoing ...
Keiji Hirai   +16 more
doaj   +1 more source

Estimation of the relationship between FGF-21 and glucose homeostasis, residual renal function and peritoneal functional parameters adjusted over time.

open access: yes, 2016
Estimation of the relationship between FGF-21 and glucose homeostasis, residual renal function and peritoneal functional parameters adjusted over time.
M. Auxiliadora Bajo (3176688)   +8 more
core   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

Benefits of preserving residual renal function in peritoneal dialysis [PDF]

open access: yesKidney International, 2008
Residual renal function (RRF) is of paramount importance in patients with end-stage renal disease, with benefits that go beyond contributing to achievement of adequacy targets. Several studies have found that RRF rather than overall adequacy (as estimated from total small solute removal rates) is an essential marker of patient and, to a lesser extent ...
Marrón, Belén   +4 more
openaire   +3 more sources

Renal artery stenosis-when to screen, what to stent? [PDF]

open access: yes, 2014
Renal artery stensosis (RAS) continues to be a problem for clinicians, with no clear consensus on how to investigate and assess the clinical significance of stenotic lesions and manage the findings.
Thomas M. MacDonald   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy